Health Care & Life Sciences » Pharmaceuticals | Tianjin Chase Sun Pharmaceutical Co. Ltd.

Tianjin Chase Sun Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,062
2,816
3,348
3,802
3,313
4,161
Cost of Goods Sold (COGS) incl. D&A
331
479
592
987
983
1,307
Gross Income
1,731
2,337
2,757
2,815
2,331
2,853
SG&A Expense
1,339
1,857
2,130
2,072
1,681
2,274
EBIT
387
-
557
794
650
560
Unusual Expense
-
10
1
5
128
309
Non Operating Income/Expense
10
1
6
4
56
58
Interest Expense
7
8
10
20
17
14
Pretax Income
402
511
618
783
575
317
Income Tax
60
70
82
123
128
108
Equity in Affiliates
-
9
-
1
9
7
Consolidated Net Income
341
449
536
661
447
216
Net Income
340
447
535
659
451
211
Net Income After Extraordinaries
340
447
535
659
451
211
Net Income Available to Common
340
447
535
659
451
211
EPS (Basic)
0.13
0.18
0.20
0.22
0.15
0.07
Basic Shares Outstanding
2,524
2,514
2,675
3,011
3,011
2,981
EPS (Diluted)
0.13
0.17
0.20
0.22
0.15
0.07
Diluted Shares Outstanding
2,524
2,579
2,720
3,011
3,011
2,981
EBITDA
431
525
619
891
764
700
Other Operating Expense
-
5
7
69
50
19
Non-Operating Interest Income
8
9
19
16
14
16
Minority Interest Expense
1
2
1
3
4
5

About Tianjin Chase Sun Pharmaceutical Co.

View Profile
Address
Quanfa West Road
Tianjin Tianjin 301700
China
Employees -
Website http://www.chasesun.cn
Updated 07/08/2019
Tianjin Chase Sun Pharmaceutical Co., Ltd. engages in the investment, manufacturing, and distribution of pharmaceuticals products. Its business includes Chinese herb preparation, Chinese medicinal granule, synthetic drugs, biotech drugs, medical apparatus, and therapies. The company was founded on September 23, 1996 and is headquartered in Tianjin, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.